Advertisement

Topics

STAT Plus: Pharmalittle: Retail drug spending growth slows; Roche looks to leapfrog in lung cancer race

09:23 EST 7 Dec 2017 | STAT

Roche reported that its Tecentriq immunotherapy drug slowed progression of lung cancer and helped patients live longer in a late-stage study.

Original Article: STAT Plus: Pharmalittle: Retail drug spending growth slows; Roche looks to leapfrog in lung cancer race

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: Retail drug spending growth slows; Roche looks to leapfrog in lung cancer race"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...